1/9
08:02 am
vor
Vor Biopharma (NASDAQ:VOR) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $50.00 price target on the stock.
Low
Report
Vor Biopharma (NASDAQ:VOR) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $50.00 price target on the stock.
1/9
07:47 am
vor
Rating for VOR
Low
Report
Rating for VOR
1/9
07:47 am
vor
Rating for VOR
Low
Report
Rating for VOR
1/9
06:13 am
vor
Vor Bio initiated with a Buy at Citi
Low
Report
Vor Bio initiated with a Buy at Citi
12/19
11:23 am
vor
Rating for VOR
Medium
Report
Rating for VOR